Patty Allen

Zafgen Inc (NASDAQ: ZFGN) said on Wednesday that a patient has died during a late-stage trial conducted by the company for its Beloranib drug. The company commented that there is still a 33 percent chance that the death was on the placebo arm. Analysts at RBC Capital Markets spoke with management...